Pharmacokinetics of Drugs Administered to Children

Part of paid clinical trials in Durham, North Carolina.

Sponsor
Duke University
Study ID
NCT03481881
Status
Recruiting
Apply to this trial

Conditions

  • Pediatric ALL

Eligibility Criteria

Sex
ALL
Age
0 Years - 20 Years
Healthy Volunteers
Not accepted

Interventions

  • Standard of care drug — DRUG
    This study is collecting PK data on children prescribed the following drugs of interest per standard of care: dexmedetomidine, bosentan, furosemide, chlorothiazide, ethacrynic acid, bumetanide, hydromorphone, tacrolimus, ampicillin, gentamicin, caffeine, fentanyl, midazolam, foscarnet, hydroxychloroquine, and moxifloxacin.

Study Details

This is a prospective study of children \<21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.

Key Dates

Start date
Aug 14, 2013
Status verified
Jan 2026
Primary completion
Aug 14, 2033
Completion
Aug 14, 2033

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

Area under the curve (AUC) [ Time Frame: Data will be collected throughout the hospital or outpatient stay up to 90 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Duke UniversityDurhamNorth Carolina27710
Rachel Greenberg, MD
[email protected]
919-668-4725

Find similar trials in Durham, NC

By research site
Duke University· Durham, NC

Related Studies